(Q44483005)

English

Identification of baseline clinical factors which predict medical treatment failure of benign prostatic hyperplasia: an observational cohort study.

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12814681%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Identification of baseline clinical factors which predict medical treatment failure of benign prostatic hyperplasia: an observational cohort study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12814681%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

prostatic hypertrophy

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12814681%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12814681%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

Woo Jin Ko

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12814681%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Sun Il Kim

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12814681%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

language of work or name

0 references

publication date

1 July 2003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12814681%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

European Urology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12814681%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

44

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12814681%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12814681%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

94-9; discussion 99-100

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12814681%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

A Randomized, Placebo-Controlled Multicenter Study of the Efficacy and Safety of Terazosin in the Treatment of Benign Prostatic Hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900199-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term efficacy and safety of terazosin in patients with benign prostatic hyperplasia. Terazosin Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900199-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Doxazosin for benign prostatic hyperplasia: long-term efficacy and safety in hypertensive and normotensive patients. The Multicenter Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900199-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900199-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment satisfaction of patients with lower urinary tract symptoms: randomised controlled trials vs. real life practice

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900199-4

7 January 2021

based on heuristic

inferred from DOI database lookup

One-year follow-up of 2829 patients with moderate to severe lower urinary tract symptoms treated with alfuzosin in general practice according to IPSS and a health-related quality-of-life questionnaire. BPM Group in General Practice

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900199-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900199-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900199-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: Meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900199-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-Term Risk Of Re-Treatment Of Patients Using α-Blockers For Lower Urinary Tract Symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900199-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Longitudinal changes in peak urinary flow rates in a community based cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900199-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural history of prostatism: risk factors for acute urinary retention

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900199-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900199-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate volume and serum prostate-specific antigen as predictors of acute urinary retention. Combined experience from three large multinational placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900199-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0302-2838(03)00199-4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12814681%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12814681%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44483005&oldid=1507688634"